{"disease":{"id":"neuromyelitis-optica-spectrum-disorders","name":"neuromyelitis optica spectrum disorders"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06643858","title":"Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT03900221","title":"French Registry for Monitoring Pregnancies for Multiple Sclerosis","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05204459","title":"MS-ResearchBiomarkerS","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT07164924","title":"Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT07202494","title":"Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT06541626","title":"Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT02200770","title":"N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"MedImmune LLC","has_results":true},{"nct_id":"NCT04101058","title":"Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04388072","title":"An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT07420296","title":"Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":198,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT03330418","title":"A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":178,"lead_sponsor_name":"RemeGen Co., Ltd.","has_results":false},{"nct_id":"NCT07132398","title":"Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":170,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT06763848","title":"Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder","phase":"NA","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06413654","title":"A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Shanghai Jiaolian Drug Research and Development Co., Ltd","has_results":false},{"nct_id":"NCT03350633","title":"Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT06829524","title":"HANDLE-a Real World Study on Satralizumab in NMOSD","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT06068829","title":"Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Feng Jinzhou","has_results":false},{"nct_id":"NCT06620809","title":"The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":69,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07526298","title":"Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT06865274","title":"Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06869278","title":"A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06697535","title":"A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Guangzhou JOYO Pharma Co., Ltd","has_results":false},{"nct_id":"NCT06212245","title":"A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":33,"lead_sponsor_name":"Hansoh BioMedical R&D Company","has_results":false},{"nct_id":"NCT06485232","title":"Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT06724809","title":"Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":21,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05871658","title":"Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Yuanqi Zhao,MD","has_results":false},{"nct_id":"NCT04146285","title":"A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Bio-Thera Solutions","has_results":false},{"nct_id":"NCT04670770","title":"An Open Label Study of the Effects of SHR1459 in NMOSDs Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Reistone Biopharma Company Limited","has_results":false},{"nct_id":"NCT03062579","title":"A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Fu-Dong Shi","has_results":false},{"nct_id":"NCT06888622","title":"BLAZE-Limiting Approach in NMOSD","phase":"","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Huashan Hospital","has_results":false}],"total":30},"guidelines":[],"source":"Drug Landscape verified database"}